Showing results (1671-1680 of 1,763) with videos related to
Sort By:
Pageof 177
Journal of Insect Science (Online)|April 28, 2021
Technological Advances to Address Current Issues in Entomology: 2020 Student DebatesLina Bernaola, Molly Darlington, Kadie Britt, et al.Aesthetic Surgery Journal|April 6, 2019
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Single-Dose, Phase III, Non-Inferiority Study Comparing PrabotulinumtoxinA and OnabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult PatientsBerthold-Josef Rzany, Benjamin Ascher, Rui L Avelar, et al.Plos One|August 10, 2023
How do perceptions of Covid-19 risk impact pregnancy-related health decisions? A convergent parallel mixed-methods study protocolMeredith Vanstone, Rebecca H Correia, Michelle Howard, et al.Annals of Hematology|September 27, 2024
Rosai-Dorfman-Destombes disease in adults: a single center experienceEmily Leung, Collin Pryma, Stephen Murphy, et al.Frontiers in Neurology|April 11, 2019
Best Practices for Long-Term Monitoring and Follow-Up of Alemtuzumab-Treated MS Patients in Real-World Clinical SettingsKrista Barclay, Robert Carruthers, Anthony Traboulsee, et al.Rheumatology Advances in Practice|June 17, 2025
Management of septic arthritis in adults with a hot swollen joint: British Society for Rheumatology guideline scopeNikita Arumalla, Victoria B Allen, Kavina Shah, et al.Multiple Sclerosis and Related Disorders|December 6, 2021
Diffusely abnormal white matter in clinically isolated syndrome is associated with parenchymal loss and elevated neurofilament levelsI M Vavasour, P Becquart, J Gill, et al.Journal of Medicinal Chemistry|March 18, 2005
Identification and biological evaluation of 4-(3-trifluoromethylpyridin-2-yl)piperazine-1-carboxylic acid (5-trifluoromethylpyridin-2-yl)amide, a high affinity TRPV1 (VR1) vanilloid receptor antagonistDevin M Swanson, Adrienne E Dubin, Chandra Shah, et al.Nature Medicine|January 14, 2022
SARS-CoV-2 infection and COVID-19 vaccination rates in pregnant women in ScotlandSarah J Stock, Jade Carruthers, Clara Calvert, et al.European Journal of Pharmacology|September 11, 2002
SCH 206272: a potent, orally active tachykinin NK(1), NK(2), and NK(3) receptor antagonistJohn C Anthes, Richard W Chapman, Christian Richard, et al.Pageof 177